Jylamvomethotrexate
According to the FDA label: JYLAMVO is a folate analog metabolic inhibitor indicated for the: Treatment of adults and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen ( 1.1 ) Treatment of adults with mycosis fungoides ( 1.1 ) Treatment of adults with relapsed or refractory non-Hodgkin lymphoma as part of a metronomic combination regimen ( 1.1 ) Treatment of adults with rheumatoid arthritis ( 1.2 ) Treatment of pediatric patients with polyarticular…
407,275 adverse event reports submitted to the FDA (1999–2026)
Top Reported Adverse Events
The most frequently reported events in association with Jylamvo in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.
Show these terms with plain-language definitions
Tap any term below for a plain-language definition.
Drug Ineffective 74,890 reports
A report that the medication did not work as expected for the person taking it. This is a reporting category, not a sign the drug is defective. It simply means someone felt it was not helping their condition.
Full definition in the glossary →Rheumatoid Arthritis 37,965 reports
An autoimmune condition where the immune system attacks the joints, causing pain and swelling. It often appears in reports because it is a condition being treated, not always a reaction.
Full definition in the glossary →Arthralgia 36,133 reports
Pain 35,293 reports
A general report of physical discomfort, used when no more specific location is given.
Full definition in the glossary →Off Label Use 33,920 reports
Using a medication for a condition or in a way that the FDA has not officially approved. This is common and often legal, and a report of it does not mean something went wrong. Doctors sometimes prescribe drugs off label based on their judgment.
Full definition in the glossary →Fatigue 29,021 reports
Extreme tiredness or lack of energy that does not improve with rest.
Full definition in the glossary → See all drugs reporting this event →Nausea 23,860 reports
The feeling of sickness in your stomach that often comes before vomiting.
Full definition in the glossary → See all drugs reporting this event →Joint Swelling 22,273 reports
Swelling in or around a joint.
Full definition in the glossary →Headache 20,864 reports
Pain in the head or upper neck.
Full definition in the glossary → See all drugs reporting this event →Rash 19,880 reports
An area of irritated, red, or bumpy skin.
Full definition in the glossary → See all drugs reporting this event →Condition Aggravated 19,695 reports
A report that the person's existing health condition got worse. This describes a worsening of something the person already had, not necessarily a new problem caused by the drug.
Full definition in the glossary →Drug Intolerance 19,679 reports
A report that the person could not tolerate a medication, often due to uncomfortable effects.
Full definition in the glossary →Diarrhoea 18,233 reports
Loose or watery bowel movements, often frequent. Also spelled diarrhea in American English.
Full definition in the glossary → See all drugs reporting this event →Pain in Extremity 17,810 reports
Pain in an arm or leg.
Full definition in the glossary →Pyrexia 17,049 reports
The medical term for fever, meaning a raised body temperature.
Full definition in the glossary → See all drugs reporting this event →
Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.
Who Is Reporting
Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.
By Sex
View reporter sex data as a table
| Sex | Reports |
|---|---|
| Female | 256,397 |
| Male | 107,319 |
| Unknown | 1,344 |
By Age Group
View age group data as a table
| Age group | Reports |
|---|---|
| 0-17 | 27,699 |
| 18-34 | 21,642 |
| 35-49 | 46,987 |
| 50-64 | 86,006 |
| 65-74 | 46,547 |
| 75+ | 23,744 |
This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.
Reported Outcomes
Outcomes recorded in FAERS reports that included Jylamvo. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.
View outcome data as a table
| Outcome | Reports |
|---|---|
| Other Serious | 229,227 |
| Hospitalization | 116,493 |
| Non-Serious | 99,445 |
| Death | 33,052 |
| Life-Threatening | 21,616 |
| Disability | 16,029 |
Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.
Report Volume Over Time
Number of FAERS reports received per quarter for Jylamvo. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.
View report trend as a table
| Year | Reports |
|---|---|
| 1999 | 3 |
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 5,129 |
| 2005 | 5,083 |
| 2006 | 4,968 |
| 2007 | 7,783 |
| 2008 | 8,996 |
| 2009 | 9,159 |
| 2010 | 9,676 |
| 2011 | 10,611 |
| 2012 | 14,958 |
| 2013 | 16,975 |
| 2014 | 16,960 |
| 2015 | 20,299 |
| 2016 | 21,743 |
| 2017 | 22,398 |
| 2018 | 31,888 |
| 2019 | 32,097 |
| 2020 | 39,611 |
| 2021 | 26,413 |
| 2022 | 29,144 |
| 2023 | 26,787 |
| 2024 | 23,044 |
| 2025 | 19,921 |
| 2026 (partial) | 3,623 |
The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.
Medications commonly reported with Jylamvo
In FDA adverse event reports that mention Jylamvo, these medications appeared most often in the same report.
- Adalimumab (107,758 reports)
- Etanercept (102,996 reports)
- Folic Acid (99,049 reports)
- Prednisone (85,619 reports)
- Infliximab (53,531 reports)
This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.
Related Drugs
Other medications with similar adverse event profiles in FDA FAERS reports.
Data Source
This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.
View this data on the FDA website →Data last updated: June 2026